WallStreetZenWallStreetZen

NASDAQ: PRTG
Portage Biotech Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Be the first to know when Wall Street analysts revise their PRTG stock forecasts and price targets.

Forecast return on equity

Is PRTG forecast to generate an efficient return?
Company
-31.02%
Industry
0.1%
Market
71.96%
PRTG's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PRTG forecast to generate an efficient return on assets?
Company
-24.87%
Industry
0.12%
PRTG is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PRTG vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PRTG$3.65N/AN/A
ABEO$3.31$20.00+504.23%Strong Buy
NRXP$0.89$2.00+124.72%Buy
PRAX$1.01$7.00+593.07%Buy
HOOK$1.13$6.00+430.97%Strong Buy
View Top Biotech Stocks

Portage Biotech Stock Forecast FAQ

What is PRTG's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: PRTG) forecast ROE is -31.02%, which is considered weak.

If you're new to stock investing, here's how to buy Portage Biotech stock.

What is PRTG's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: PRTG) forecast ROA is -24.87%, which is lower than the forecast US Biotechnology industry average of 0.12%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.